News
Market and company headlines
BTSGAll
Loading
09:00-23:00Oct 142 Stories
BrightSpring Health Services (BTSG) Could Be 10% Undervalued On Its Raised 2026 Outlook
BrightSpring Health Services (BTSG) is back in focus after management twice raised its 2026 outlook, attributing the change to firm demand, improved profitability, and smoother than expected integration of recent home health acquisitions. Recent trading has been choppy for BrightSpring Health Services, with the share price up 5.06% over the past month but still down 7.06% across the last 90 days, even as the year to date share price return of 64.97% and 1 year total shareholder return of...
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?
BrightSpring's shares surge 67.3% year to date, fueled by strong pharmacy and provider growth, improving profitability and a brighter 2026 outlook.
03:00Oct 141 Story
07:00Oct 131 Story
10:00-16:00Oct 122 Stories
Top Stock Reports for Oracle, American Express & Progressive
Oracle, American Express and Progressive face contrasting challenges and growth drivers, from underperformance to rising expenses, premium growth and strategic investments.
Top Healthcare Stocks: Playing Offense And Defense For The Win
The best healthcare stocks for Q4 2026 and beyond provide a combination of strong growth and defensive qualities. Click here to see the top 3 stocks.
08:00Oct 11 Story
09:00Sep 301 Story
13:00Sep 291 Story
07:00Sep 271 Story
08:00Sep 251 Story
09:00-12:00Sep 232 Stories
BrightSpring Health Services (BTSG) Wins Fund Backing, Is It Still Undervalued?
BrightSpring Health Services (BTSG) is back on investor radar after Carillon Eagle Small Cap Growth Fund highlighted the healthcare provider in its second quarter 2026 letter, citing revenue and adjusted EBITDA ahead of IPO expectations. Despite the upbeat fund commentary, BrightSpring Health Services has hit a softer patch on the screen, with the share price at US$56.55 after a 1-day share price return of 1.24% but a 90-day share price return that has declined 16.36%. The year-to-date share...
Zacks.com featured highlights include Centene, BrightSpring Health Services and Delek US
Momentum stocks Centene, BrightSpring Health Services and Delek US show strong annual gains despite recent weekly pullbacks.
09:00-11:00Sep 212 Stories
Here’s What Lifted BrightSpring Health Services (BTSG)
Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. The letter can be downloaded here. Small-cap stocks rallied broadly in the second quarter, with the Russell 2000 Growth Index (+25.71%) outpacing Value +17.24%). Information Technology (+46.79%) led all sectors, supported by solid gains […]
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
10:00Sep 161 Story
11:00-21:00Sep 152 Stories
BrightSpring Health Services, Inc. (BTSG) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
BrightSpring Health Services, Inc. (BTSG) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 3:20 PM EDTCompany ParticipantsJennifer...
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.
14:00Sep 111 Story
07:00Aug 181 Story
02:00Aug 161 Story
11:00-18:00Aug 132 Stories
Should BrightSpring Health Services (BTSG) Be Revalued As Earnings And Guidance Shift?
BrightSpring Health Services (BTSG) was in focus after releasing second quarter 2026 results on July 31, alongside updated full year revenue guidance that shaped investor expectations for the rest of the year. See our latest analysis for BrightSpring Health Services. BrightSpring Health Services shares have been volatile in recent weeks, with a 3.09% 1 day share price gain following earnings offset by a 14.30% decline over 30 days. However, the year to date share price return of 55.42% and 1...
Aveanna Healthcare: Q2 Earnings Report Boosts The Stock And Reinforces My Buy Rating
Aveanna Healthcare beats Q2 2026 estimates, raises guidance, and still looks attractively valued vs. peers. Click here to read more about AVAH.
02:00-06:00Aug 132 Stories
BrightSpring Health Services (BTSG) Stock Still Looks Stretched Following Raised Outlook
BrightSpring Health Services stock has delivered a very strong 166.5% gain over the past year, yet recent pullbacks and a mixed valuation score leave investors weighing how much of the good news is already reflected in the price. Over the last 12 months the share price is up 166.5%, which signals that expectations for BrightSpring Health Services are already running high. Stronger revenue momentum and growth in pharmacy and care services can support a premium, while concerns around profit...
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target
BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.